Preoperative fast heart rate: A harbinger of perioperative adverse cardiac events

British Journal of Anaesthesia

Volumn 117, Issue 3, 2016, Pages 271-274

  Fo'x, P ^a   Higham, H ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN T;

ADVERSE OUTCOME; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; HEART INFARCTION; HEART MUSCLE INJURY; HEART RATE; HIGH RISK PATIENT; HUMAN; PERIOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SILENT MYOCARDIAL ISCHEMIA; TACHYCARDIA; COMPLICATION; ELECTROCARDIOGRAPHY; POSTOPERATIVE COMPLICATION; EDITORIAL; MAJOR ADVERSE CARDIAC EVENT; RESTING HEART RATE;

ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE PERIOD; TACHYCARDIA;

EID: 84995479945     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aew265     Document Type: Editorial

References (43)

1. Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371: 1839-47
2. Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med 2014; 370: 1494-503
3. Devereaux PJ, Sessler DI, Leslie K, et al. Clonidine in patients undergoing noncardiac surgery. N Engl J Med 2014; 370: 1504-13
4. Landesberg G, Beattie WS, Mosseri M, Jaffe AS, Alpert JS. Perioperativemyocardial infarction. Circulation 2009; 119: 2936-44
5. Landesberg G, Mosseri M, Zahger D, et al. Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-Type ischemia. J Am Coll Cardiol 2001; 37: 1839-45
6. Slogoff S, Keats AS. Does perioperative myocardial ischemia lead to postoperative myocardial infarction?. Anesthesiology 1985; 62: 107-14
7. Shah KB, Kleinman BS, Rao TL, Jacobs HK, Mestan K, Schaafsma M. Angina and other risk factors in patients with cardiac diseases undergoing noncardiac operations. Anesth Analg 1990; 70: 240-7
8. Reich DL, Bennett-Guerrero E, Bodian CA, Hossain S, WinfreeW, Krol M. Intraoperative tachycardia and hypertension are independently associated with adverse outcome in noncardiac surgery of long duration. Anesth Analg 2002; 95: 273-7, table of contents
9. Hartmann B, Junger A, Rohrig R, et al. Intra-operative tachycardia and peri-operative outcome. Langenbecks Arch Surg 2003; 388: 255-60
10. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-9
11. Sander O, Welters ID, Foex P, Sear JW. Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med 2005; 33: 81-8
12. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001; 104: 1477-82
13. Bohm M, Reil JC, Deedwania P, Kim JB, Borer JS. Resting heart rate: risk indicator and emerging risk factor in cardiovascular disease. Am J Med 2015; 128: 219-28
14. Dierckx R, Cleland JG, Parsons S, et al. Prescribing patterns to optimize heart rate: analysis of 1, 000 consecutive outpatient appointments to a single heart failure clinic over a 6-month period. J Am Coll Cadrdiol Heart Fail 2015; 3: 224-30
15. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 1990; 323: 1781-8
16. Fleisher LA, Rosenbaum SH, Nelson AH, Barash PG. The predictive value of preoperative silent ischemia for postoperative ischemic cardiac events in vascular and nonvascular surgery patients. Am Heart J 1991; 122: 980-6
17. Neill F, Sear JW, French G, et al. Increases in serum concentrations of cardiac proteins and the prediction of early postoperative cardiovascular complications in noncardiac surgery patients. Anaesthesia 2000; 55: 641-7
18. Levy M, Heels-Ansdell D, Hiralal R, et al. Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-Analysis. Anesthesiology 2011; 114: 796-806
19. Devereaux PJ, Chan MT, Alonso-Coello P, et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 2012; 307: 2295-304
20. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Circulation 2012; 126: 2020-35
21. Berwanger O, Le Manach Y, Suzumura EA, et al. Association between pre-operative statin use and major cardiovascular complications among patients undergoing non-cardiac surgery: the VISION study. Eur Heart J 2016; 37: 177-85
22. Botto F, Alonso-Coello P, ChanMT, et al.Myocardial Injury after Noncardiac Surgery: ALarge, International, ProspectiveCohort Study Establishing Diagnostic Criteria, Characteristics, Predictors, and 30-day Outcomes. Anesthesiology 2014; 120: 564-78
23. Nathoe HM, Van Klei WA, Beattie WS. Perioperative troponin elevation: always myocardial injury, but not always myocardial infarction. Anesth Analg 2014; 119: 1014-6
24. Abbott T, Ackland G, Archbold A, et al. Preoperative heart rate and myocardial injury after non-cardiac surgery: results of the VISION study. Br J Anaesth 2016; 117: 172-81
25. Fox K, Ford I, Steg PG, Tendera M, Ferrari R. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, doubleblind, placebo-controlled trial. Lancet 2008; 372: 807-16
26. Fox K, Borer JS, CammAJ, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol 2007; 50: 823-30
27. Raby KE, Brull SJ, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 1999; 88: 477-82
28. Wijeysundera DN, Duncan D, Nkonde-Price C, et al. Perioperative Beta Blockade inNoncardiac Surgery: ASystematic Review for the 2014ACC/AHAGuideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 64: 2406-25
29. Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 64: e77-e137
30. Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European SocietyofCardiology (ESC)., and the European Society of Anaesthesiology (ESA). Eur Heart J 2014; 35: 2383-431
31. Stone DH, Goodney PP, Schanzer A, et al. Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery. J Vasc Surg 2011; 54: 779-84
32. Mistry R, Walker D. Perioperative beta-blockade: might the baby go out with the bath water?. Clin Med (Lond). 2014; 14: 604-7
33. Slogoff S, Keats AS. Does chronic treatment with calcium entry blocking drugs reduce perioperative myocardial ischemia?. Anesthesiology 1988; 68: 676-80
34. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 2003; 97: 623-33
35. Borer JS, Bohm M, Ford I, et al. Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure (fromthe SHIFT study). Am J Cardiol 2014; 113: 497-503
36. Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R. Ivabradine in stable coronary artery disease without clinical heart failure. N Engl J Med 2014; 371: 1091-9
37. Lo Sapio P, Gensini GF, Bevilacqua S, et al. The role of ivabradine in the incidence of perioperative coronary complications in patients undergoing vascular surgery. Int J Cardiol 2013; 168: 4352-3
38. Weber M, Luchner A, Seeberger M, et al. Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. Eur Heart J 2013; 34: 853-62
39. Foucrier A, Rodseth R, Aissaoui M, et al. The long-Term impact of early cardiovascular therapy intensification for postoperative troponin elevation after major vascular surgery. Anesth Analg 2014; 119: 1053-63
40. Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol 2007; 49: 1272-8
41. Devereaux PJ, Sessler DI. Cardiac Complications and Major Noncardiac Surgery. N Engl J Med 2016; 374: 1394-5
42. Reeder MK, Goldman MD, Loh L, et al. Postoperative hypoxaemia after major abdominal vascular surgery. Br J Anaesth 1992; 68: 23-6
43. Gill NP, Wright B, Reilly CS. Relationship between hypoxaemic and cardiac ischaemic events in the perioperative period. Br J Anaesth 1992; 68: 471-3